0001193805-24-000827.txt : 20240618
0001193805-24-000827.hdr.sgml : 20240618
20240618210059
ACCESSION NUMBER: 0001193805-24-000827
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240614
FILED AS OF DATE: 20240618
DATE AS OF CHANGE: 20240618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Markels John
CENTRAL INDEX KEY: 0001803424
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38942
FILM NUMBER: 241053777
MAIL ADDRESS:
STREET 1: C/O SANGAMO THERAPEUTICS, INC.
STREET 2: POINT RICHMOND TECH CTR, 501 CANAL BLVD.
CITY: RICHMOND
STATE: CA
ZIP: 94804
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcturus Therapeutics Holdings Inc.
CENTRAL INDEX KEY: 0001768224
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8589002660
MAIL ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
e663728_4-markels.xml
X0508
4
2024-06-14
0
0001768224
Arcturus Therapeutics Holdings Inc.
ARCT
0001803424
Markels John
C/O ARCTURUS THERAPEUTICS HOLDINGS INC.
10628 SCIENCE CENTER DRIVE, SUITE 250
SAN DIEGO
CA
92121
1
0
0
0
0
Common Stock
2024-06-14
4
M
0
3131
0.00
A
3131
D
Deferred Stock Units
0.00
2024-06-14
4
M
0
3131
0.00
D
Common Stock
3131
0
D
Stock option (right to buy)
31.00
2024-06-14
4
A
0
15000
0.00
A
2034-06-14
Common Stock
15000
15000
D
Each deferred stock unit is economically equivalent to one share of the Issuer's common stock, was granted on August 1, 2023 as a portion of the Reporting Person's 2023 annual grant, and vested at the Issuer's 2024 annual meeting of stockholders, which occurred on June 14, 2024.
Represents a portion of the 2023 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer.
Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer.
/s/ Ilan Katz, attorney-in-fact
2024-06-18